Downloads
Abstract
Objectives: To estimate the effects of neoadjuvant chemotherapy in patients with advanced stage ovarian cancer.
Materials: 31 patients with stage III - IV ovarian cancer who were treated by neoadjuvant chemotherapy in department of Obstetrics and Gynecology of Hue Central Hospital, from January 2009 to December 2013.
Method: A perspective study.
Results: The median age was 53.8 ± 17.6. 87.1% of patients were staged III when first diagnosed. 19.4% of them responsed to the regimen and 83.9% reached optimal cytoreduction. Rate of recurrence is 25.8% and mean time intervals of recurrence is 8.6 ± 7.2 months.
Conclusion: Neoadjuvant chemotherapy is one of the most effective treatments for patients with advanced stage ovarian cancer.
References
Bhoola S, William J. Hoskins (2006) Diagnosis and Management of Epithelial Ovarian Cancer, Obstet Gynecol, 107:1399-1410.
Chappuis PO, Goffin J, Wong N, Perret C, Ghadirian P, Tonin PN, Foulkes WD (2002) A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer, J Med Genet, 39:608-610.
Deo SVS, Hemant G, Shukla NK, Raina V, Lalit K, Srinivas G (2006) Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced epithelial ovarian cancer, Indian Journal of Cancer, 43(3):117-121.
Fleming GF, Ronnett BM, Seidman J, Zaino RJ, Rubin SC (2009) Epithelial ovarian cancer, Principles and Practice of Gynecologic Oncology, 764-835.
Holstein SA, Hohl RJ (2008) Chemotherapy of Gynecology cancers, Chemotherapy source book, The 4th edition, 448-463.
Kikkawa F, Nawa A, Ino K, Shibata K, Kajiyama H, Nomura S (2006) Advances in treatment of epithelial ovarian cancer, Nagoya J. Med. Sci, 68:19-26.
Le T, Faught W, Hopkins L, (2008) The Importance of CA125 Normalization During Neoadjuvant Chemotherapy Followed by Planned Delayed Surgical Debulking in Patients With Epithelial Ovarian Cancer, J Obstet Gynaecol Can, 30(8):665-670.
Muazzam IA, Rizvi F, Sidique MK, Syed AA, Azfar M, Zahid KF (2010) Neoadjuvant chemotherapy in ovarian cancer, Ann. Pak. Inst. Med. Sci. 6(2):85-90.
Ramirez I, Chon HS, Apte SM (2011) The role of surgery in the management of epithelial ovarian cancer, Cancer Control, 8(18):22-30.
Robinson WR, Barnett G, MD, Rogers AS (2008) Neoadjuvant chemotherapy prior to intraperitoneal chemotherapy in women with advanced ovarian cancer, Community oncology, 5:376-380.
Schorge JO, Miller DS (2008) Epithelial ovarian cancer, Williams Gynecology, Chapter 35.
Vergote I, Trope CG, Amant F, Ehlen T, Reed NS, Casado A (2011) Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer, Journal of Clinical oncology, 29(31):4076-4078.
| Published | 19-08-2016 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 36 (2016) | |
| Section | Original article | |
| DOI | 10.38103.36.9 | |
| Keywords | Neoadjuvant chemotherapy, advanced stage ovarian cancer |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Journal of Clinical Medicine Hue Central Hospital